---
title: "Stelara (ustekinumab), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Stelara (ustekinumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Administration and Preparation. Questions: Where should Stelara be injected? What should Stelara look like before injection? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/stelara/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Stelara (ustekinumab), all indications: Dosing and administration questions

Manufacturer: Janssen Biotech, Inc.  
Prescribing information: [Stelara](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf)  
Indication pages: [Plaque psoriasis](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis)

## Administration

<a id="stelara-injection-sites"></a>

### Where should Stelara be injected?

> “It is recommended that each injection be administered at a different anatomic 
> location (such as upper arms, gluteal regions, thighs, or any quadrant of 
> abdomen) than the previous injection, and not into areas where the skin is 
> tender, bruised, erythematous, or indurated. When using the vial, a 1 mL syringe 
> with a 27 gauge, ½ inch needle is recommended.”

Source: [STELARA: Prescribing information, page 3, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=3)

## Preparation

<a id="stelara-solution-appearance"></a>

### What should Stelara look like before injection?

> “Prior to administration, visually inspect STELARA for particulate matter and 
> discoloration. STELARA is a colorless to light yellow solution and may contain a 
> few small translucent or white particles. Do not use STELARA if it is discolored 
> or cloudy, or if other particulate matter is present. STELARA does not contain 
> preservatives; therefore, discard any unused product remaining in the vial 
> and/or syringe.”

Source: [STELARA: Prescribing information, page 3, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=3)

## Related pages
- [Medical information: Stelara (ustekinumab): All indications](https://www.evicenter.com/medical-information/stelara)
- [Indication](https://www.evicenter.com/medical-information/stelara/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/stelara/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/stelara/safety)
- [Specific populations](https://www.evicenter.com/medical-information/stelara/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/stelara/drug-interactions)
- [Storage and supply](https://www.evicenter.com/medical-information/stelara/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/stelara/access-and-coverage)
